Dealmakers
Sharif Tabebordbar On Raising $51 Million With His Team To Transform Pain Into Hope For Muscle Wasting Diseases
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:45
- Mas informaciones
Informações:
Sinopsis
In a recent interview with Sharif Tabebordbar, co-founder of Kate Therapeutics, we delved into his personal journey, scientific endeavors, and the establishment of a groundbreaking company focused on developing gene therapies for genetic muscle diseases.
